NCT06344767已完成不适用
Positive Estrogen Receptor (ER) Expression Assessed by 18F-fluoroestradiol Positron Emission Tomography/Computed Tomography (18F-FES PET/CT) in the Metastatic Breast Cancer (MBC) with ER- Negative Primary Tumor
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 19
- 试验地点
- 1
- 主要终点
- Progression free survival (PFS)
研究概览
简要总结
To investigate the treatment pattern and efficacy of patients with negative primary ER lesion but positive ER expression in MBC using a novel convenient way of 18F-fluoroestradiol positron emission tomography/computed tomography (18F-FES PET/CT).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients diagnosed with breast cancer (according to International Classification of Diseases 10th Revision) with confirmed metastasis, regardless of being de novo diagnosed or progressed from a nonmetastatic stage.
- •MBC patients who underwent 18F-FES PET/CT at the Fudan University Shanghai Cancer Center between 2012 and 2023
- •Patients diagnosed with primary ER-negative tumor and who were yet to receive any systemic therapy during the advanced stage
排除标准
- •Patients with incomplete medical records and those diagnosed with secondary primary tumors
结局指标
主要结局
Progression free survival (PFS)
时间窗: 6 weeks
Progression free survival
次要结局
- Adverse events(6 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Negative ER Expression Assessed by 18F-FES PET/CT in the MBC With ER-positive Primary TumorBreast CancerNCT05797987Fudan University52
尚未招募
Unknown
Evaluating utility of Oestrogen and Progesterone Receptor biomarkers for prediction of colorectal CancerCTRI/2024/05/068054Datta Meghe Institute of Higher Education & Research (DMIHER)
进行中（未招募）
2 期
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast CancerAdvanced Triple-Negative Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast CarcinomaRecurrent Breast CarcinomaNCT03941730Mayo Clinic8
招募中
2 期
4FMFES-PET Imaging of ER+ Advanced Breast CancersER+ Breast CancerNCT04824014Centre de recherche du Centre hospitalier universitaire de Sherbrooke150
已完成
2 期
Palbociclib and FES PETBreast CancerNCT02806050University Medical Center Groningen30